Page last updated: 2024-11-05

trifluoperazine and Bile Duct Cancer

trifluoperazine has been researched along with Bile Duct Cancer in 2 studies

Research Excerpts

ExcerptRelevanceReference
"We have previously demonstrated that tamoxifen inhibits the growth of human cholangiocarcinoma cells in culture and inhibits tumor growth when cells are injected into nude mice."3.70Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin. ( McDonald, JM; Pan, G; Phillips, JO; Pickens, A; Siegal, GP; Thompson, JA; Vickers, SM; Ying, W, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y1
Pawar, P1
Pan, G2
Ma, L1
Liu, H1
McDonald, JM2
Vickers, SM1
Pickens, A1
Phillips, JO1
Ying, W1
Thompson, JA1
Siegal, GP1

Other Studies

2 other studies available for trifluoperazine and Bile Duct Cancer

ArticleYear
Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells.
    Journal of cellular biochemistry, 2008, Feb-15, Volume: 103, Issue:3

    Topics: Apoptosis; Bile Duct Neoplasms; Calcium; Calmodulin; Caspase 8; Cholangiocarcinoma; Death Domain Rec

2008
Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin.
    The American journal of pathology, 1999, Volume: 155, Issue:1

    Topics: Animals; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Calmodulin; Cholangiocarcinoma; E

1999